| Filed On | Filing |
|---|---|
| 13 Nov 2026 | Form 4 |
| 06 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Reports record revenue of $1,023.6 million, up 7% year-over-year, net income of $20.3 million, up 1,782% year-over-year, and record adjusted EBITDA(1) of $77.2 million, up 13% year-over-year for the three months ended September 30, 2026 |
| 30 Oct 2026 | SCHEDULE 13G/A |
| 13 Oct 2026 |
Form 4: Vong John, SVP - Accounting (PAO)
Gave up 556 shares to cover exercise price or tax ($20.9K) |
| 08 Oct 2026 |
Form 4: Sim Brandon, CEO and President
Gave up 9,889 shares to cover exercise price or tax ($366K) |
| 08 Oct 2026 |
Form 4: Lam Thomas S., Director
Gave up 2,624 shares to cover exercise price or tax ($97.1K) |
| 06 Oct 2026 |
Form 4: Basho Chandan, COO and CFO
Gave up 2,092 shares to cover exercise price or tax ($75.1K) |
| 23 Sep 2026 |
8-K: Regulation FD Disclosure
2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of the Securities Act and Section 21E of the Exchange Act. Forw... |
| 23 Sep 2026 |
8-K: Material Cybersecurity Incidents
Astrana Health, Inc. (the “Company”) recently became aware that its subsidiary Astrana Health Management, Inc. detected unusual activity within its environment. |
| 17 Sep 2026 |
Form 4: Vong John, SVP - Accounting (PAO)
Gave up 96 shares to cover exercise price or tax ($3.68K) |
| 15 Sep 2026 |
8-K: Regulation FD Disclosure
2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of the Securities Act and Section 21E of the Exchange Act. Forw... |
| 09 Sep 2026 |
Form 4: Sim Brandon, CEO and President
Gave up 7,163 shares to cover exercise price or tax ($276K) |
| 08 Sep 2026 |
Form 4: Basho Chandan, COO and CFO
Gave up 1,790 shares to cover exercise price or tax ($68.9K) |
| 01 Sep 2026 |
Form 4: Kitayama Mitchell W, Director
Returned 8,500 shares to the issuer ($315K) |
| 18 Aug 2026 |
Form 4: Schmidt David, Director
Received 20,000 shares by exercise or conversion ($100K) · Returned 20,000 shares to the issuer ($772K) |
| 11 Aug 2026 |
Form 3: Vong John, SVP - Accounting (PAO)
Holds 22,426 shares of Common Stock |
| 11 Aug 2026 |
Form 4: Sobotka Glenn, Former Officer
Returned 11,793 shares to the issuer |
| 10 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Reports revenue of $972.5 million, up 49% year-over-year, net income of $18.5 million, up 81% year-over-year, and adjusted EBITDA(1) of $68.9 million, up 43% year-over-year for the three months ended June 30, 2026 |
Loading...